Breast cancer
Results
Phase 2
This trial looked at either ixabepilone with bevacizumab (Avastin) or paclitaxel (Taxol) with bevacizumab for breast cancer that has come back after treatment.
Recruitment start: 1 March 2007
Recruitment end: 7 March 2008
Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.
Dr. Mark Verrill
Bristol-Myers Squibb
Experimental Cancer Medicine Centre (ECMC)
Last reviewed: 06 Nov 2013
CRUK internal database number: 894
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
